# Switching From Insulin to Sulfonylurea in Diabetes Associated With Variants in MODY Genes

> **NCT04239586** · PHASE4 · UNKNOWN · sponsor: **Haukeland University Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Maturity-Onset Diabetes of the Young, Type 3
- Maturity Onset Diabetes of the Young, Type 1
- Childhood Diabetes Mellitus
- Insulin-dependent Diabetes Mellitus

## Interventions

- **DRUG:** Sulfonylurea

## Key facts

- **NCT ID:** NCT04239586
- **Lead sponsor:** Haukeland University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-04-18
- **Primary completion:** 2022-04
- **Final completion:** 2022-04
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2020-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04239586

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04239586, "Switching From Insulin to Sulfonylurea in Diabetes Associated With Variants in MODY Genes". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT04239586. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*